Stay updated on RTX-240 Combo with Pembrolizumab in Clinical Trial
Sign up to get notified when there's something new on the RTX-240 Combo with Pembrolizumab in Clinical Trial page.

Latest updates to the RTX-240 Combo with Pembrolizumab in Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA site-wide NIH notice announces the transition from “Artificial Intelligence” to “Super Intelligence” terminology. The displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.7%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe displayed ClinicalTrials.gov site revision changes from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check46 days agoChange DetectedA new Revision: v3.7.0 entry was added to the version history. The previous Revision: v3.6.6 entry was removed from the list.SummaryDifference0.1%

- Check60 days agoChange DetectedThe record history now shows a new site revision, updating from v3.6.5 to v3.6.6, indicating a recent UI/software update of the page.SummaryDifference0.1%

- Check81 days agoChange DetectedA new revision label 'Revision: v3.6.5' appears in the history list, replacing 'Revision: v3.6.4'. This reflects a software release update for the page's UI, with no changes to the study data shown.SummaryDifference0.1%

- Check103 days agoChange DetectedA new revision entry for v3.6.4 has been added to the page's history, replacing the previous v3.6.3 entry. This reflects an internal update to the record history metadata rather than changes to the visible study information.SummaryDifference0.1%

Stay in the know with updates to RTX-240 Combo with Pembrolizumab in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RTX-240 Combo with Pembrolizumab in Clinical Trial page.